Ownership

Robert Nelsen - Director, 10%+ Owner at Prime Medicine, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Stock Symbol: PRME on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Robert Nelsen - trading volume in the past year for Prime Medicine, Inc.

	Shares	%	Avg Price	Total $
Buys	+3.2M	100%	$6.25	+$20M
Sells
Net	+3.2M	100%		+$20M

Holdings reported by Robert Nelsen for Prime Medicine, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	6.13M	$38.3M	$6.25	Feb 15, 2024	By ARCH Venture Fund X, L.P.
Common Stock	6.13M	$38.3M	$6.25	Feb 15, 2024	By ARCH Venture Fund X Overage, L.P.
Common Stock	3.2M	$20M	$6.25	Feb 15, 2024	By ARCH Venture Fund XII, L.P.
Common Stock	16.1K	$101K	$6.25	Feb 15, 2024	Indirect
Stock Option (right to buy)	45K			Jun 12, 2024	Direct	Common Stock

Transactions reported by Robert Nelsen for Prime Medicine, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.